Marina S. Rajadurai

About

Marina S. Rajadurai received her M. Sc. degree in Chemistry in 1998 from D. I. Mendeleev Russian Chemical-Technological University, Moscow, Russia. After working for 4 years as an Engineer, at the A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Moscow, Russia, she joined the PhD programme at the same institute. She completed her PhD in 2006, during this period she worked at Max Planck Institute for Polymer Research, Mainz, Germany as a Visiting Graduate Student.
In 2008 she joined as a Post Doctoral Fellow at the Institute of Life Sciences, University of Hyderabad Campus where her major research interests were on synthesis of novel heterocyclic bioactive scaffolds. In 2010 she was subsequently appointed as Junior Research Scientist at the Dr. Reddy’s Institute of Life Sciences where she is currently working now. Her research interest is focused on development of the new nano-scale fluorescent sensors, nano-medicinal chemistry, and nanoparticles-mediated drug delivery.
Dr. Marina is also co-promoter of the start-up biotech company Vegrandis Therapeutic engaged in discovery of new therapies for critical unmet needs. At Vegrandis Therapeutics she is in charge of chemistry and nano-chemistry based endeavors.

Employment

• Dr. Reddy’s Institute of Life Sciences Senior Research Scientist
  2021 - Present
• Dr. Reddy’s Institute of Life Sciences Research Scientist
  2014 - 2021
• Vegrandis Therapeutics Head
  2013 - 2021
• Dr. Reddy’s Institute of Life Sciences Jr. Research Scientist
  2010 - 2013
• Institute of Life Sciences Post Doctoral Fellow
  2008 - 2009
• INEOS, Russian Academy of Sciences Research Fellow
  2002 - 2007

Education

• N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences PhD
  2001 - 2006
• D. I. Mendeleev Russian Chemical-Technological University M. Sc.
  1991 - 1998

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• A microneedle transdermal patch loaded with iron(ii) nanoparticles for non-invasive sustained delivery to combat anemia
  Materials Advances 2024 DOI: 10.1039/D3MA01166F
  +Save
• Aptamer Directed Anti-Microbial Nanoparticles
  Indian Patent 2022
  +Save
• Sustained Release Compositions
  International PCT Application 2021
  +Save
• Pd-catalysed general access to 7-membered N/O-heterocyclic compounds as potential agents against inflammation
  Chemical Communications 2021 DOI: 10.1039/d1cc04140a
  +Save
• Tuning the sensitivity towards mercury via cooperative binding to d-fructose: dual fluorescent chemosensor based on 1,8-naphthyridine-boronic acid derivative
  RSC Advances 2021 DOI: 10.1039/D1RA02122B
  +Save
• Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model
  Current Nanomedicine 2019 DOI: 10.2174/2468187308666180925143701
  +Save
• Ni nanoparticles on polyaromatic hyperbranched polymer support as a mild, tunable, and sustainable catalyst for catalytic transfer hydrogenation
  Journal of Nanoparticle Research 2019 DOI: 10.1007/s11051-019-4533-2
  +Save
• Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs
  Drug Delivery and Translational Research 2018 DOI: 10.1007/s13346-018-0527-3
  +Save
• Magnetic Nanoparticle Formulations for Targeted Delivery of Drugs to Lungs for Treatment of Pulmonary Diseases
  International Application (PCT) 2017
  +Save
• Antibacterial Nanoparticles Based on Fluorescent 3‐Substituted Uridine Analogue
  ChemistrySelect 2017 DOI: 10.1002/slct.201601708
  +Save